JohnEWagnerMD
Pediatric Hematology & Oncology • Minneapolis, MNProfessor, Pediatrics, University of Minnesota Medical School, Minneapolis
Dr. Wagner is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
516 Delaware St SE
PWB Fifth floor Suite 5100 Clinic 5B
Minneapolis, MN 55455Phone+1 612-626-2663Fax+1 612-626-4074
Education & Training
Johns Hopkins UniversityFellowship, Hematology and Medical Oncology, 1984 - 1987
Duke University HospitalResidency, Pediatrics, 1981 - 1984
Sidney Kimmel Medical College at Thomas Jefferson UniversityClass of 1981
Certifications & Licensure
MN State Medical License 1991 - 2025
MD State Medical License 1984 - 1991- American Board of Pediatrics Pediatrics
- American Board of Pediatrics Pediatric Hematology-Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013
- Elected Member The American Society for Clinical Investigation, 2000
- Elected Member American Association of Physicians
Clinical Trials
- T-Cell Depletion in Unrelated Donor Marrow Transplantation Start of enrollment: 1993 Nov 01
- Bone Marrow Transplantation in Treating Patients With Leukemia Start of enrollment: 1996 Apr 01
- Donor Umbilical Cord Blood Transplant in Treating Patients With Hematologic Cancer Start of enrollment: 1999 Oct 01
- Join now to see all
Publications & Presentations
PubMed
- 1363 citationsSuccessful adoptive transfer and in vivo expansion of human haploidentical NK cells in patients with cancer.Jeffrey S. Miller, Yvette Soignier, Angela Panoskaltsis-Mortari, Sarah A. McNearney, Gong H. Yun
Blood. 2005-04-15 - 204 citationsMarked increased risk of Epstein-Barr virus-related complications with the addition of antithymocyte globulin to a nonmyeloablative conditioning prior to unrelated umb...Claudio G. Brunstein, Daniel J. Weisdorf, Todd E. DeFor, Juliet N. Barker, Jakub Tolar
Blood. 2006-10-15 - 15 citationsInside out: regenerative medicine for recessive dystrophic epidermolysis bullosaMichael J Vanden Oever, Kirk Twaroski, Mark J. Osborn, John E. Wagner, Jakub Tolar
Pediatric Research. 2018-01-01
Abstracts/Posters
- Outcomes of Chronic Graft-Versus-Host Disease (cGVHD) Following Matched Sibling Donor (MSD) Versus Umbilical Cord Blood Transplant (UCBT)John E. Wagner, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
- Mgta-456, an Aryl Hydrocarbon Receptor (AHR) Antagonist Based Expansion of CD34+ Hematopoietic Stem Cells (HSC), Permits Selection of Better HLA Matched Cord Blood Uni...John E. Wagner, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
- Romiplostim Improves Platelet Recovery after UCB TransplantJohn E. Wagner, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
Press Mentions
Top Doctors: A Legacy of DiscoveryJuly 1st, 2021
Grant Support
- Inducible Regulatory T Cells for the Prevention and Treatment of GVHDNational Heart, Lung and Blood Institute2012–Present
- First in Human Study to Evaluation the Safety and Tolerability of HSC835Novartis2011–Present
- Production Assistance for Cellular TherapiesNational Heart, Lung and Blood Institute2003–Present
- Biology and Transplantation of the Human Stem CellNational Cancer Institute1997–Present
Professional Memberships
- Member
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
